Some of you may have seen the headlines this week about JDRF and Amylin investigating a new diabetes treatment — essentially a mixture of insulin and pramlintide (brand name Symlin), two substances that are only FDA approved for entirely separate use at the moment. Interesting!
The reasoning seems highly practical: “A co-formulated therapy that harnesses the benefit of both hormones might better mimic the natural physiology of the pancreas and simplify dosing decisions.”
Also in…
Read more »
Hello PWDs. You are now entering the DiabetesMine Sunday Funnies zone, featuring the work of lovable diabetes snark-artist Haidee Merritt. Missed last week’s Funnies? Check ‘em out here.
Your Funnies for today……
Read more »
A week ago, the media was all abuzz about a new study published in the New England Journal of Medicine showing that the oral drug Actos can prevent diabetes. At first we at the ‘Mine didn’t pay much attention, because of course we’re more concerned with what happens to people who already have diabetes. But the buzz didn’t stop. Forbes blogger Matthew Herper wrote a great piece about why side effects make this a bad…
Read more »
With all the talk about mice in cure research (over 2 million results for “mice diabetes research” on Google!), you might think there is absolutely no way for you — a human — to participate in the magic of modern science. But there are actually a lot of studies going on right now that need participation from PWDs with both type 1 and type 2 diabetes.
Worried about risking your health on something too experimental? …
Read more »
By
AmyT on
January 3, 2011
Happy New Year, everyone! I’ve been mostly off-line this past week, attempting to enjoy the “break” while cleaning and sorting out our fresh-from-construction home. But even in that daze, I couldn’t help noticing all the fuss about MannKind’s Afrezza, which was supposed to be ruled upon by the FDA on Dec. 29.
The FDA has requested an additional four weeks to make a decision on this new inhalable insulin, after having postponed the decision by…
Read more »
